Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 3
1995 2
1996 4
1997 3
1998 3
1999 2
2001 3
2002 2
2003 1
2004 2
2005 6
2006 3
2007 3
2008 1
2009 3
2010 3
2011 5
2012 6
2013 3
2014 1
2015 6
2016 4
2017 4
2018 5
2019 10
2020 12
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Results by year
Filters applied: . Clear all
Page 1
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Del Mastro L, Mansutti M, Bisagni G, Ponzone R, Durando A, Amaducci L, Campadelli E, Cognetti F, Frassoldati A, Michelotti A, Mura S, Urracci Y, Sanna G, Gori S, De Placido S, Garrone O, Fabi A, Barone C, Tamberi S, Bighin C, Puglisi F, Moretti G, Arpino G, Ballestrero A, Poggio F, Lambertini M, Montemurro F, Bruzzi P; Gruppo Italiano Mammella investigators. Del Mastro L, et al. Among authors: garrone o. Lancet Oncol. 2021 Oct;22(10):1458-1467. doi: 10.1016/S1470-2045(21)00352-1. Epub 2021 Sep 17. Lancet Oncol. 2021. PMID: 34543613 Clinical Trial.
How I treat squamous ENT cancer.
Merlano MC, Denaro N, Galizia D, Garrone O. Merlano MC, et al. Among authors: garrone o. ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019. ESMO Open. 2019. PMID: 31555490 Free PMC article. Review.
Knowing the tumour microenvironment to optimise immunotherapy.
Merlano MC, Abbona A, Denaro N, Garrone O. Merlano MC, et al. Among authors: garrone o. Acta Otorhinolaryngol Ital. 2019 Feb;39(1):2-8. doi: 10.14639/0392-100X-2481. Acta Otorhinolaryngol Ital. 2019. PMID: 30936573 Free PMC article. Review.
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial.
Del Mastro L, De Placido S, Bruzzi P, De Laurentiis M, Boni C, Cavazzini G, Durando A, Turletti A, Nisticò C, Valle E, Garrone O, Puglisi F, Montemurro F, Barni S, Ardizzoni A, Gamucci T, Colantuoni G, Giuliano M, Gravina A, Papaldo P, Bighin C, Bisagni G, Forestieri V, Cognetti F; Gruppo Italiano Mammella (GIM) investigators. Del Mastro L, et al. Among authors: garrone o. Lancet. 2015 May 9;385(9980):1863-72. doi: 10.1016/S0140-6736(14)62048-1. Epub 2015 Mar 2. Lancet. 2015. PMID: 25740286 Clinical Trial.
Heterogeneity of colon cancer: from bench to bedside.
Merlano MC, Granetto C, Fea E, Ricci V, Garrone O. Merlano MC, et al. Among authors: garrone o. ESMO Open. 2017 Aug 22;2(3):e000218. doi: 10.1136/esmoopen-2017-000218. eCollection 2017. ESMO Open. 2017. PMID: 29209524 Free PMC article. Review.
Immune-related response criteria: light and shadows.
Merlano M, Occelli M, Garrone O. Merlano M, et al. Among authors: garrone o. ESMO Open. 2016 Jul 7;1(4):e000082. doi: 10.1136/esmoopen-2016-000082. eCollection 2016. ESMO Open. 2016. PMID: 27843632 Free PMC article. No abstract available.
104 results